Across TCGA pan-cancer cohorts, SEPTIN14P3 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated SEPTIN14P3 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher SEPTIN14P3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SEPTIN14P3 expression acts as an unfavorable survival marker, although some lineages such as LUSC show a favorable association.

STAD, SKCM, and GBM are the cancer types where SEPTIN14P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	II,III,IV	0.149	0.645	<.001	81	view →
SKCM	OS	Tertile	All	0.175	0.787	<.001	51	view →
GBM	DFS	Tertile	All	0.068	0.288	.003	18	view →
LUSC	OS	Tertile	II,III,IV	1.000	0.376	.043	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: SEPTIN14P3 tumor-vs-normal RNA expression · all SEPTIN14P3 data types